{
  "id": 8838765,
  "title": "Chinese biopharma stocks jump as U.S. weighs keeping door open to drug deals",
  "url": "https://urgent.news/2026/09/21/chinese-biopharma-stocks-jump-as-u-s-weighs-keeping-door-open-to-drug-8838765",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-09-21T04:20:33.000Z",
  "source": {
    "name": "CNBC",
    "slug": "cnbc",
    "url": "https://www.cnbc.com/2026/09/21/chinese-biopharma-stocks-jump-as-us-plans-to-continue-drug-licensing-deals-.html"
  },
  "original_language": "en",
  "account": null,
  "summary": "Chinese biopharma stocks rose on Monday after a report that the U.S. may continue to allow most drug licensing deals with Chinese firms.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "CNBC World",
        "title": "Chinese biopharma stocks jump as U.S. weighs keeping door open to drug deals",
        "url": "https://urgent.news/2026/09/21/chinese-biopharma-stocks-jump-as-u-s-weighs-keeping-door-open-to-drug",
        "published": "2026-09-21T04:20:33.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}